Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination

Brain

Volumn 135, Issue 5, 2012, Pages 1395-1411

  Sidiropoulos, Páris N M ^a   Miehe, Michaela ^a   Bock, Thomas ^a   Tinelli, Elisa ^a   Oertli, Carole I ^a   Kuner, Rohini ^b   Meijer, Dies ^c   Wollscheid, Bernd ^a   Niemann, Axel ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Charcot Marie Tooth disease; dynamin 2; endocytosis; hereditary motor and sensory neuropathy; myelination

Indexed keywords

CLATHRIN; DYNAMIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; MOUSE; MYELINATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL;

EID: 84860643209     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws061     Document Type: Article

References (46)

1. Agarwal N, Offermanns S, Kuner R. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia. Genesis 2004; 38: 122-9.
2. Altschuler Y, Barbas SM, Terlecky LJ, Tang K, Hardy S, Mostov KE, et al. Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol 1998; 143: 1871-81.
3. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006; 5: 573-88.
4. Berti C, Nodari A, Wrabetz L, Feltri ML. Role of integrins in peripheral nerves and hereditary neuropathies. Neuromolecular Med 2006; 8: 191-204.
5. Bitoun M, Durieux AC, Prudhon B, Bevilacqua JA, Herledan A, Sakanyan V, et al. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Hum Mutat 2009; 30: 1419-27.
6. Claeys KG, Zuchner S, Kennerson M, Berciano J, Garcia A, Verhoeven K, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain 2009; 132: 1741-52.
7. Durieux AC, Prudhon B, Guicheney P, Bitoun M. Dynamin 2 and human diseases. J Mol Med 2010; 88: 339-50.
8. Durieux AC, Vignaud A, Prudhon B, Viou MT, Beuvin M, Vassilopoulos S, et al. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. Hum Mol Genet 2010; 19: 4820-36.
9. Dyck PJ, Chance P, Lebo R, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia: W.B. Saunders Company; 1993. p. 1094-136.
10. Ferguson SM, Brasnjo G, Hayashi M, Wolfel M, Collesi C, Giovedi S, et al. A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 2007; 316: 570-4.
11. Ferguson SM, Raimondi A, Paradise S, Shen H, Mesaki K, Ferguson A, et al. Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Developmental cell 2009; 17: 811-22.
12. Fischer D, Herasse M, Bitoun M, Barragan-Campos HM, Chiras J, Laforet P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006; 129: 1463-9.
13. Heymann JA, Hinshaw JE. Dynamins at a glance. J Cell Sci 2009; 122: 3427-31.
14. Hofmann A, Gerrits B, Schmidt A, Bock T, Bausch-Fluck D, Aebersold R, et al. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells. Blood 2010; 116: e26-34.
15. Jaegle M, Ghazvini M, Mandemakers W, Piirsoo M, Driegen S, Levavasseur F, et al. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev 2003; 17: 1380-91.
16. Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, Suzek BE, et al. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 2009; 10: 136
17. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002; 74: 5383-92.
18. Keller LC, Romijn EP, Zamora I, Yates JR 3rd, Marshall WF. Proteomic analysis of isolated chlamydomonas centrioles reveals orthologs of ciliary-disease genes. Curr Biol 2005; 15: 1090-8.
19. Kenniston JA, Lemmon MA. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients. EMBO J 2010; 29: 3054-67.
20. Lange V, Malmstrom JA, Didion J, King NL, Johansson BP, Schafer J, et al. Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics 2008; 7: 1489-500.
21. Liu YW, Surka MC, Schroeter T, Lukiyanchuk V, Schmid SL. Isoform and splice-variant specific functions of dynamin-2 revealed by analysis of conditional knock-out cells. Mol Biol Cell 2008; 19: 5347-59.
22. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Developmental cell 2006; 10: 839-50.
23. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284-8.
24. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004; 304: 700-3.
25. Motley A, Bright NA, Seaman MN, Robinson MS. Clathrin-mediated endocytosis in AP-2-depleted cells. J Cell Biol 2003; 162: 909-18.
26. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003; 75: 4646-58.
27. Newbern J, Birchmeier C. Nrg1/ErbB signaling networks in Schwann cell development and myelinatio. Semin Cell Dev Biol 2010; 21: 922-28.
28. Nicholson G, Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. Neuromolecular Med 2006; 8: 123-30.
29. Ozcelik M, Cotter L, Jacob C, Pereira JA, Relvas JB, Suter U, et al. Pals1 is a major regulator of the epithelial-like polarization and the extension of the myelin sheath in peripheral nerves. J Neurosci 2010; 30: 4120-31.
30. Pedrioli PG, Eng JK, Hubley R, Vogelzang M, Deutsch EW, Raught B, et al. A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol 2004; 22: 1459-66.
31. Pereira JA, Lebrun-Julien F, Suter U. Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci 2012; 35: 123-34.
32. Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 2004; 5: 133-47.
33. Ramachandran R, Surka M, Chappie JS, Fowler DM, Foss TR, Song BD, Schmid SL. The dynamin middle domain is critical for tetramerization and higher-order self-assembly. EMBO J 2007; 26: 559-66.
34. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 2008; 56: 1578-89.
35. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
36. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2008; 314: 3093-106.
37. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003; 4: 714-26.
38. Stendel C, Roos A, Kleine H, Arnaud E, Ozcelik M, Sidiropoulos PN, et al. SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling. Brain 2010; 133: 2462-74.
39. Tanabe K, Takei K. Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant. J Cell Biol 2009; 185: 939-48.
40. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Diemer K, Guo N, et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003; 31: 334-41.
41. Vassilieva EV, Gerner-Smidt K, Ivanov AI, Nusrat A. Lipid rafts mediate internalization of beta1-integrin in migrating intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008; 295: G965-76.
42. Wang L, Barylko B, Byers C, Ross JA, Jameson DM, Albanesi JP. Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers. J Biol Chem 2010; 285: 22753-7.
43. Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 2009; 27: 378-86.
44. Woodhoo A, Alonso MB, Droggiti A, Turmaine M, D'Antonio M, Parkinson DB, et al. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci 2009; 12: 839-37.
45. Yates JR 3rd, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-36.
46. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, De Jonghe P, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 2005; 37: 289-94.